Lenvatinib plus pembrolizumab for previously treated, advanced triple-negative breast cancer: Early results from the multicohort phase 2 LEAP-005 study

Autores: Chung, H. C.; Saada Bouzid, E.; Longo Munoz, F.; Yanez, E.; Im, S. A.; Castañón Álvarez, Eduardo; Graham, D. M.; Garcia Corbacho, J.; Lopez, J.; Ghori, R.; Dutcus, C.; Smith, A.; Norwood, K.; Lopez, J.; Ghori, R.; Dutcus, C.; Smith, A.; Norwood, K.; Gomez Roca, C.